Pages that link to "Q28277824"
Jump to navigation
Jump to search
The following pages link to Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival (Q28277824):
Displaying 50 items.
- Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease (Q24289344) (← links)
- Aspirin, cyclooxygenase inhibition and colorectal cancer (Q24598813) (← links)
- Implications of preoperative hypoalbuminemia in colorectal surgery (Q26745630) (← links)
- Molecular Subtypes and Personalized Therapy in Metastatic Colorectal Cancer (Q26747329) (← links)
- Aspirin and Colorectal Cancer Prevention and Treatment: Is It for Everyone? (Q26749127) (← links)
- Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies (Q26751511) (← links)
- Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances (Q26768427) (← links)
- Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer (Q26774690) (← links)
- Molecular phenotypes of colorectal cancer and potential clinical applications (Q26785725) (← links)
- Anti-angiogenesis or pro-angiogenesis for cancer treatment: focus on drug distribution (Q26796955) (← links)
- Molecular cancer prevention: Current status and future directions (Q26797207) (← links)
- What a tangled web we weave: emerging resistance mechanisms to inhibition of the phosphoinositide 3-kinase pathway (Q26825780) (← links)
- The gastrointestinal tumor microenvironment (Q26827391) (← links)
- Can Aspirin and Cancer Prevention be Ageless Companions? (Q26827455) (← links)
- Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression (Q26852716) (← links)
- Cancer and systemic inflammation: treat the tumour and treat the host (Q26858815) (← links)
- Epigenetic regulations of inflammatory cyclooxygenase-derived prostanoids: molecular basis and pathophysiological consequences (Q26862642) (← links)
- Lifestyle Modifications and Colorectal Cancer (Q26865414) (← links)
- Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology (Q27011884) (← links)
- Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies (Q27015224) (← links)
- Chemopreventive drugs: mechanisms via inhibition of cancer stem cells in colorectal cancer (Q27026428) (← links)
- Clinical advances in molecular biomarkers for cancer diagnosis and therapy (Q27027560) (← links)
- Prostaglandin E receptor 4 (EP4) promotes colonic tumorigenesis (Q27340480) (← links)
- Molecular targets of aspirin and cancer prevention (Q27687847) (← links)
- The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis (Q27852988) (← links)
- Beyond RAS and BRAF: a target rich disease that is ripe for picking (Q28066095) (← links)
- The biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized care (Q28066460) (← links)
- Epidemiology of colorectal cancer (Q28067871) (← links)
- Molecular predictive markers in tumors of the gastrointestinal tract (Q28070583) (← links)
- Mechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancer (Q28076490) (← links)
- Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human Studies (Q28081491) (← links)
- Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer (Q28084346) (← links)
- Epithelial cancers in the post-genomic era: should we reconsider our lifestyle? (Q28391921) (← links)
- Chemoprevention of metastasis (Q28395816) (← links)
- PIK3CA Mutation (Q28445019) (← links)
- Phospho-aspirin-2 (MDC-22) inhibits estrogen receptor positive breast cancer growth both in vitro and in vivo by a redox-dependent effect (Q28544712) (← links)
- Microenvironmental regulation of tumor progression and metastasis (Q29615504) (← links)
- Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis. (Q30244608) (← links)
- Prognostic role of tumor PIK3CA mutation in colorectal cancer: a systematic review and meta-analysis (Q30248900) (← links)
- Resveratrol and aspirin eliminate tetraploid cells for anticancer chemoprevention (Q30573152) (← links)
- Distinguishing grade I meningioma from higher grade meningiomas without biopsy (Q31006300) (← links)
- Genomic Profiling in Gastrointestinal Cancer: Are We Ready To Use These Data to Make Treatment Decisions? (Q31012680) (← links)
- Overexpression of RBBP6, alone or combined with mutant TP53, is predictive of poor prognosis in colon cancer (Q31121056) (← links)
- Concomitant tumor expression of EGFR and TATI/SPINK1 associates with better prognosis in colorectal cancer (Q31143290) (← links)
- Targeted therapies for pancreatic adenocarcinoma: Where do we stand, how far can we go? (Q33361738) (← links)
- EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics (Q33566687) (← links)
- FosB transcription factor regulates COX-2 expression in colorectal cancer cells without affecting PGE2 expression (Q33599214) (← links)
- Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review (Q33732199) (← links)
- Erlotinib, erlotinib-sulindac versus placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancer. (Q33924908) (← links)
- Effective inhibition of colon cancer cell growth with MgAl-layered double hydroxide (LDH) loaded 5-FU and PI3K/mTOR dual inhibitor BEZ-235 through apoptotic pathways (Q33934922) (← links)